Biographical Sketch
Burak Sade, MD, was born in Ankara, Turkey. He has been a clinical associate in the Brain Tumor and Neuro-oncology Center and the Department of Neurosurgery of the Neurological Institute since 2007. His clinical interests include brain tumors, meningiomas and skull base tumors in particular, surgical treatment of other skull base pathologies, and Chiari malformation.
Dr. Sade is the recipient of the 2006 Integra Foundation Award and the 2007 Synthes Skull Base Award from the American Association of Neurological Surgeons / Congress of Neurological Surgeons Joint Section on Tumors in recognition of his research on benign tumors of the nervous system, and on skull base surgery, respectively. He is also the co-author of the study, which received the 2008 Integra Foundation Award (Award recipient: Joung H. Lee, MD). In 2006, Dr. Sade received the ?Do?ent? title (An academic title equivalent of Associate Professor) bestowed by the Higher Education Council of Turkey (highest academic body in Turkey) as an acknowledgement of his academic achievements in the field of Neurosurgery. He was also selected for the Global Directory of Who?s Who, a registry of outstanding professionals in their respective fields.
To date, Dr. Sade has authored more than 100 peer-reviewed journal manuscripts, book chapters, and abstracts on various neurosurgical topics, particularly on meningiomas, and other skull base tumors.
Specialty Interests
chiari malformation, Meningiomas, outcome research, Skull Base Surgery, benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, gamma knife, gamma knife and radiosurgery, Gamma Knife Radiosurgery, stereotactic surgery, tumors of the brain and spine
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Sade’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.
